Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Effect of Low-Sodium versus Conventional Sodium Dialysate on Left Ventricular Mass in Home and Self-Care Satellite Facility Hemodialysis Patients: A Randomized Clinical Trial.

Marshall MR, Vandal AC, de Zoysa JR, Gabriel RS, Haloob IA, Hood CJ, Irvine JH, Matheson PJ, McGregor DOR, Rabindranath KS, Schollum JBW, Semple DJ, Xie Z, Ma TM, Sisk R, Dunlop JL.

J Am Soc Nephrol. 2020 Mar 18. pii: ASN.2019090877. doi: 10.1681/ASN.2019090877. [Epub ahead of print]

PMID:
32188697
2.

The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF).

Donnellan S, Wright DFB, Roberts JA, Duffull SB, Schollum JBW, Putt TL, Wallis SC, Walker RJ.

Eur J Clin Pharmacol. 2020 Feb;76(2):239-247. doi: 10.1007/s00228-019-02792-0. Epub 2019 Dec 9.

PMID:
31814045
3.

Recruitment and participant baseline characteristics in the dialysis outcomes in those aged 65 years or older study.

McNoe B, Schollum JBW, Derrett S, Marshall MR, Henderson A, Samaranayaka A, Walker RJ.

BMC Nephrol. 2019 Apr 23;20(1):137. doi: 10.1186/s12882-019-1328-8.

4.

Endovascular Renal Denervation in End-Stage Kidney Disease Patients: Cardiovascular Protection-A Proof-of-Concept Study.

Hoye NA, Wilson LC, Wilkins GT, Jardine DL, Putt TL, Samaranayaka A, Schollum JBW, Walker RJ.

Kidney Int Rep. 2017 May 4;2(5):856-865. doi: 10.1016/j.ekir.2017.04.012. eCollection 2017 Sep.

5.

Predictors of Health Deterioration Among Older Adults After 12 Months of Dialysis Therapy: A Longitudinal Cohort Study From New Zealand.

Derrett S, Samaranayaka A, Schollum JBW, McNoe B, Marshall MR, Williams S, Wyeth EH, Walker RJ.

Am J Kidney Dis. 2017 Dec;70(6):798-806. doi: 10.1053/j.ajkd.2017.06.023. Epub 2017 Aug 18.

PMID:
28823582
6.

To dialyse or delay: a qualitative study of older New Zealanders' perceptions and experiences of decision-making, with stage 5 chronic kidney disease.

Lovell S, Walker RJ, Schollum JB, Marshall MR, McNoe BM, Derrett S.

BMJ Open. 2017 Mar 29;7(3):e014781. doi: 10.1136/bmjopen-2016-014781.

7.

A Population Pharmacokinetic Model for 51Cr EDTA to Estimate Renal Function.

Kuan IHS, Duffull SB, Putt TL, Schollum JBW, Walker RJ, Wright DFB.

Clin Pharmacokinet. 2017 Jun;56(6):671-678. doi: 10.1007/s40262-016-0489-x.

PMID:
27943221
8.

GFR may not accurately predict aspects of proximal tubule drug handling.

Putt TL, Duffull SB, Schollum JB, Walker RJ.

Eur J Clin Pharmacol. 2014 Oct;70(10):1221-6. doi: 10.1007/s00228-014-1733-7. Epub 2014 Aug 20.

PMID:
25135059
9.

Rationale and design of the Myocardial Microinjury and Cardiac Remodeling Extension Study in the Sodium Lowering in Dialysate trial (Mac-SoLID study).

Dunlop JL, Vandal AC, de Zoysa JR, Gabriel RS, Gerber LM, Haloob IA, Hood CJ, Irvine JH, Matheson PJ, McGregor DO, Rabindranath KS, Schollum JB, Semple DJ, Marshall MR.

BMC Nephrol. 2014 Jul 21;15:120. doi: 10.1186/1471-2369-15-120.

10.

Omeprazole-induced acute interstitial nephritis: a possible Th1-Th17-mediated injury?

Berney-Meyer L, Hung N, Slatter T, Schollum JB, Kitching AR, Walker RJ.

Nephrology (Carlton). 2014 Jun;19(6):359-65. doi: 10.1111/nep.12226.

PMID:
24629073
11.

Endovascular renal denervation: a novel sympatholytic with relevance to chronic kidney disease.

Hoye NA, Baldi JC, Putt TL, Schollum JB, Wilkins GT, Walker RJ.

Clin Kidney J. 2014 Feb;7(1):3-10. doi: 10.1093/ckj/sft130. Epub 2013 Nov 8.

12.

Chronic interstitial fibrosis in the rat kidney induced by long-term (6-mo) exposure to lithium.

Walker RJ, Leader JP, Bedford JJ, Gobe G, Davis G, Vos FE, deJong S, Schollum JB.

Am J Physiol Renal Physiol. 2013 Feb 1;304(3):F300-7. doi: 10.1152/ajprenal.00182.2012. Epub 2012 Nov 21.

13.

Adult urinary tract infection.

Schollum JB, Walker RJ.

Br J Hosp Med (Lond). 2012 Apr;73(4):218-23. Review. No abstract available.

PMID:
22585198
14.

Dietary sodium loading in normotensive healthy volunteers does not increase arterial vascular reactivity or blood pressure.

Todd AS, Macginley RJ, Schollum JB, Williams SM, Sutherland WH, Mann JI, Walker RJ.

Nephrology (Carlton). 2012 Mar;17(3):249-56. doi: 10.1111/j.1440-1797.2011.01550.x.

PMID:
22171802
15.

Glycated albumin is the preferred marker for assessing glycaemic control in advanced chronic kidney disease.

Vos FE, Schollum JB, Walker RJ.

NDT Plus. 2011 Dec;4(6):368-75. doi: 10.1093/ndtplus/sfr140. Review.

16.

Modeling red blood cell survival data.

Korell J, Vos FE, Coulter CV, Schollum JB, Walker RJ, Duffull SB.

J Pharmacokinet Pharmacodyn. 2011 Dec;38(6):787-801. doi: 10.1007/s10928-011-9220-6. Epub 2011 Oct 14.

PMID:
21997468
17.

Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.

Vos FE, Schollum JB, Coulter CV, Manning PJ, Duffull SB, Walker RJ.

Nephrology (Carlton). 2012 Feb;17(2):182-8. doi: 10.1111/j.1440-1797.2011.01517.x.

PMID:
21883672
18.

Red blood cell survival in long-term dialysis patients.

Vos FE, Schollum JB, Coulter CV, Doyle TC, Duffull SB, Walker RJ.

Am J Kidney Dis. 2011 Oct;58(4):591-8. doi: 10.1053/j.ajkd.2011.03.031. Epub 2011 Jun 29.

PMID:
21715072
19.

Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function.

Endre ZH, Pickering JW, Walker RJ, Devarajan P, Edelstein CL, Bonventre JV, Frampton CM, Bennett MR, Ma Q, Sabbisetti VS, Vaidya VS, Walcher AM, Shaw GM, Henderson SJ, Nejat M, Schollum JB, George PM.

Kidney Int. 2011 May;79(10):1119-30. doi: 10.1038/ki.2010.555. Epub 2011 Feb 9.

20.

Anti-inflammatory effect of an insulin infusion in patients on maintenance haemodialysis: a randomized controlled pilot study.

Vos FE, Manning PJ, Sutherland WH, Schollum JB, Walker RJ.

Nephrology (Carlton). 2011 Jan;16(1):68-75. doi: 10.1111/j.1440-1797.2010.01329.x.

PMID:
21175981
21.

Omeprazole-induced acute interstitial nephritis is not related to CYP2C19 genotype or CYP2C19 phenotype.

Helsby NA, Lo WY, Simpson IJ, Voss DM, Logan KE, Searle M, Schollum JB, de Zoysa JR.

Br J Clin Pharmacol. 2010 May;69(5):516-9. doi: 10.1111/j.1365-2125.2010.03623.x.

22.

Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial).

Endre ZH, Walker RJ, Pickering JW, Shaw GM, Frampton CM, Henderson SJ, Hutchison R, Mehrtens JE, Robinson JM, Schollum JB, Westhuyzen J, Celi LA, McGinley RJ, Campbell IJ, George PM.

Kidney Int. 2010 Jun;77(11):1020-30. doi: 10.1038/ki.2010.25. Epub 2010 Feb 17.

23.

Dietary salt loading impairs arterial vascular reactivity.

Todd AS, Macginley RJ, Schollum JB, Johnson RJ, Williams SM, Sutherland WH, Mann JI, Walker RJ.

Am J Clin Nutr. 2010 Mar;91(3):557-64. doi: 10.3945/ajcn.2009.28645. Epub 2010 Jan 27.

PMID:
20107199

Supplemental Content

Loading ...
Support Center